BRG1 mutation and loss of function are important diagnostic abnormalities for the unique ovarian (SCCOHT) and thoracic (SMARCA4-DTS) cancers and are detected in increasing numbers of other malignancies [5,6,7]. This evidence concerns the gene SMARCA4 and cancer.